Document is current
Any future updates will be listed below
-
Authors
Rader, Ryan K.
Anders, Carey K.
Lin, Nancy U.
Sammons, Sarah L.
- License Information
-
More Information
Article History
Accepted: 19 March 2023
First Online: 18 April 2023
Compliance with Ethical Standards
:
: Ryan Rader has no conflicts of interest.Sarah Sammons declares research funding from Astra Zeneca, Lilly, Seagen, and Sermonix, and consulting fees from AstraZeneca, Daichii Sankyo, Foundation Medicine, Gilead, Novartis, Pfizer, Seagen, and Sermonix.Carey Anders declares research funding from PUMA, Lilly, Merck, Seattle Genetics, Nektar, Tesaro, G1-Therapeutics, ZION, Novartis, and Pfizer; consulting fees from Genentech, Eisai, IPSEN, Seattle Genetics; Astra Zeneca, Novartis, Immunomedics, Elucida, and Athenex; and royalties from UpToDate and Jones and Bartlett.Nancy Lin declares research funding from Genentech, Seattle Genetics, Merck, and Pfizer and consulting fees from Daichii Sankyo, AstraZeneca, Seattle Genetics, Prelude Therapeutics, Denali Therapeutics, and California Institute for Regenerative Medicine.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
